Bactana, a Farmington, Conn.-based development stage animal health company, raised 1.3m in ts first funding.
VivoAquatics, a Los Angeles, CA-based water management and real-time monitoring platform for hotels, resorts, fitness clubs and other commercial facilities, secured a Series A financing of undisclosed amount.
Varsity Tutors, a live learning platform that connects experts and learners in any subject, anywhere, acquired Veritas Prep, a Los Angeles-based test prep and admissions consulting company.
Edquity, a Brooklyn-based edtech and fintech company supporting students through each and every financial decision on the road to college graduation, raised $500k in funding.
Clearcover, a Chicago, IL-based smart car insurance company, raised $43m in Series B financing.
Rex, a Woodland Hills, CA-based platform to buy and sell a home, secured $45m in Series C funding.
Dosh, an Austin, Texas-based fintech app, closed a $40m Series B financing.
Keyfactor (fka Certified Security Solutions), a Cleveland, OH-based provider of secure digital identity management solutions, closed a $77m growth funding.
Beeswax, a NYC-based extensible programmatic buying platform, secured $15m in Series B funding.
Hone, a San Francisco, CA- and and New York City-based workplace training platform for modern and distributed teams, raised $3.6m in seed funding.
The Pill Club, a San Francisco, CA-based online birth control prescription and delivery service, raised $51m in Series B funding.
Trelar Logistics (fka FlexFleet Inc.), an Austin, Texas-based logistics platform, raised $2.1m in seed funding.
AXA Venture Partners, a venture capital firm investing in high-growth technology companies, completed the first closing of the second vintage of its Early Stage Fund (AVP Early Stage II) with $150m (€130m).
Urban Airship, a Portland, Ore.-based digital customer engagement company, acquired Accengage, a Paris, France-based provider of mobile CRM and push notifications.
First Light Diagnostics, a Chelmsford, Mass.-based developer of automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, closed an $8.25 million Series A-2 financing.